2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of …

EM Antman, M Hand, PW Armstrong, ER Bates… - Circulation, 2008 - Am Heart Assoc
Late-breaking clinical trials presented at the 2005 and 2006 annual scientific meetings of the
ACC, AHA, and European Society of Cardiology, as well as selected other data, were …

2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused …

FG Kushner, M Hand, SC Smith Jr, SB King III… - Circulation, 2009 - Am Heart Assoc
2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation
Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI …

2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task …

Writing Committee Members, GN Levine, ER Bates… - Circulation, 2011 - Am Heart Assoc
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention | Circulation Science
Volunteer Warning signs SearchSearch Advanced Search Donate Circulation logo Hello Guest …

ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction—executive summary: a report of the American College of Cardiology …

Writing Committee Members, EM Antman, DT Anbe… - Circulation, 2004 - Am Heart Assoc
D. Medication Assessment............................................ 610 1. Beta Blockers....................................
................. 609 2. Nitroglycerin...................................................... 610 3. Inhibition of the Renin …

2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on …

Writing Committee Members, JS Lawton… - Journal of the American …, 2022 - jacc.org
Aim The guideline for coronary artery revascularization replaces the 2011 coronary artery
bypass graft surgery and the 2011 and 2015 percutaneous coronary intervention guidelines …

[HTML][HTML] Optimal medical therapy with or without PCI for stable coronary disease

WE Boden, RA O'Rourke, KK Teo… - New England journal …, 2007 - Mass Medical Soc
Background In patients with stable coronary artery disease, it remains unclear whether an
initial management strategy of percutaneous coronary intervention (PCI) with intensive …

ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart …

EM Antman, DT Anbe, PW Armstrong, ER Bates… - Journal of the American …, 2004 - Elsevier
The process of guideline development for management of patients with acute myocardial
infarction (AMI) has undergone substantial evolution since the inaugural publication entitled …

American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (ivus …

GS Mintz, SE Nissen, WD Anderson, SR Bailey… - Journal of the American …, 2001 - jacc.org
The committee consisted of acknowledged experts in IVUS representing the ACC (10
members) and the European Society of Cardiology (2 members). Both the academic and …

2021 ACC/AHA/SCAI guideline for coronary artery revascularization: executive summary: a report of the American College of Cardiology/American Heart Association …

JS Lawton, JE Tamis-Holland, S Bangalore, ER Bates… - Circulation, 2022 - Am Heart Assoc
Aim: The executive summary of the American College of Cardiology/American Heart
Association/Society for Cardiovascular Angiography and Interventions coronary artery …

Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization …

LJ Shaw, DS Berman, DJ Maron, GBJ Mancini… - Circulation, 2008 - Am Heart Assoc
Background—Extent and severity of myocardial ischemia are determinants of risk for
patients with coronary artery disease, and ischemia reduction is an important therapeutic …